Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Low Copper Diet-A Therapeutic Option for Wilson Disease? | Children (Basel) | 2022 | 36010023 | PubTator, text mining | PubMed |
| Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis. | Biomedicines | 2022 | 36009368 | PubTator, text mining | PubMed |
| Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. | Nat Commun | 2022 | 36008377 | PubTator, text mining | PubMed |
| Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. | Bioengineering (Basel) | 2022 | 36004931 | PubTator, text mining | PubMed |
| Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. | Bioengineering (Basel) | 2022 | 36004917 | PubTator, text mining | PubMed |
| High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. | BMC Bioinformatics | 2022 | 35996075 | PubTator, text mining | PubMed |
| Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives. | Front Immunol | 2022 | 35990673 | PubTator, text mining | PubMed |
| Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer. | Front Immunol | 2022 | 35979353 | PubTator, text mining | PubMed |
| Microfluidic-Derived Detection of Protein-Facilitated Copper Flux Across Lipid Membranes. | Anal Chem | 2022 | 35969432 | PubTator, text mining | PubMed |
| Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease. | Front Aging Neurosci | 2022 | 35966780 | PubTator, text mining | PubMed |
| Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer. | Front Immunol | 2022 | 35958598 | PubTator, text mining | PubMed |
| Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35957868 | PubTator, text mining | PubMed |
| Scelestial: Fast and accurate single-cell lineage tree inference based on a Steiner tree approximation algorithm. | PLoS Comput Biol | 2022 | 35951662 | PubTator, text mining | PubMed |
| The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma. | Front Genet | 2022 | 35942287 | PubTator, text mining | PubMed |
| Generalized dystonia without Parkinsonism in an LRRK2 carrier. | Clin Park Relat Disord | 2022 | 35941989 | PubTator, text mining | PubMed |
| Pearls & Oy-sters: Challenges and Controversies in Wilson Disease. | Neurology | 2022 | 35940888 | PubTator, text mining | PubMed |
| Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer. | Pharmgenomics Pers Med | 2022 | 35923305 | PubTator, text mining | PubMed |
| Newly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter. | Hum Mol Genet | 2022 | 35913762 | PubTator, text mining | PubMed |
| Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases). | Cancer Treat Res Commun | 2022 | 35908410 | PubTator, text mining | PubMed |
| Use of the bibliometric in rare diseases: taking Wilson disease personally. | Orphanet J Rare Dis | 2022 | 35906666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=53